<DOC>
	<DOC>NCT00853970</DOC>
	<brief_summary>Efficacy study of Bromfenac Ophthalmic Solution in cataract surgery</brief_summary>
	<brief_title>Efficacy Study of Bromfenac Ophthalmic Solution in Patients Undergoing Cataract Surgery</brief_title>
	<detailed_description />
	<mesh_term>Inflammation</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Bromfenac</mesh_term>
	<mesh_term>Ophthalmic Solutions</mesh_term>
	<criteria>Male or female at least 18 years of age who are scheduled for unilateral cataract surgery Have known hypersensitivity to bromfenac or to any component of the investigational product</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2013</verification_date>
	<keyword>Pain and Inflammation as a function of cataract surgery</keyword>
</DOC>